Understanding gut health and metabolic syndrome in HIV-positive men
Official title: Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men
Funded at University of Colorado Denver · NIH-11092260 · Data updated 2026-11-12
This work explores how gut bacteria and intestinal health might contribute to metabolic syndrome in men living with HIV who have sex with men.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | August 1, 2022 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $690,739 |
| NIH project number | 5R01DK131581-04 |
| Project ID | NIH-11092260 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is relevant for HIV-positive men who have sex with men and are at risk for or experiencing metabolic syndrome.
✕Less likely to help
Patients who do not have HIV or metabolic syndrome, or who are not men who have sex with men, may not directly benefit from this specific research.
What this research studies
Many people living with HIV, especially men who have sex with men, experience metabolic syndrome, which increases their risk for heart problems. We know that gut bacteria and a healthy intestinal barrier are connected to metabolic syndrome in other groups, but this connection hasn't been fully understood in HIV-positive men. This project aims to uncover how changes in gut bacteria and a weakened intestinal barrier might lead to inflammation and metabolic syndrome in this specific population. By understanding these links, we hope to find new ways to improve health for these individuals.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for preventing or managing metabolic syndrome in HIV-positive men by targeting gut health.
How similar studies have gone: While gut microbiome links to metabolic syndrome have been observed in other populations, this specific connection in HIV-positive men who have sex with men is not yet deeply understood.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: Lozupone, Catherine — University of Colorado Denver
- Study coordinator: Lozupone, Catherine
Related research
Other NIH-funded projects on the same topics.
-
Gut health and HIV: how the gut barrier and microbiome affect metabolic health in HIV-positive men who have sex with men
A research grant is exploring how the gut bacteria and gut barrier may influence metabolic problems in HIV-positive MSM, with the goal of finding ways to reduce obesity and heart-disease risk.
-
Multi-agent AI to annotate enzymes in the human gut microbiome
A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.
-
Integrated biomarker study of metabolic syndrome in pregnant women with HIV on DTG-based ART
Researchers will look for biological signs in pregnant women with HIV on a DTG-based regimen to understand why weight gain and metabolic problems happen and how these affect pregnancy.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based ART
This project looks at why some pregnant women living with HIV on a common DTG-based therapy gain weight or develop metabolic problems, by studying their proteins and metabolites across four sites in the US and Nigeria.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based therapy
This project looks at markers in pregnant women living with HIV who are on a DTG-containing regimen to understand why some develop metabolic problems during pregnancy.
-
Mapping how gut bacteria transform drugs
Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.